Loading...
Loading...
India's losartan imports from UNITED STATES total $62.9K across 98 shipments from 15 foreign suppliers. SPRING BIO SOLUTION leads with $11.6K in import value; the top 5 suppliers together control 57.9% of this origin. Leading Indian buyers include LAURUS LABS LTD. This corridor reflects India's pharmaceutical import demand for losartan — a diversified sourcing base with multiple active suppliers from UNITED STATES.

SPRING BIO SOLUTION is the leading Losartan supplier from UNITED STATES to India, with import value of $11.6K across 4 shipments. The top 5 suppliers — SPRING BIO SOLUTION, M/S RAFF & HALL PHARMACY, Pharmaceutical Buyers Inc, PHARMACEUTICAL BUYERS, INC, Espee Biopharma Finechem LLC — collectively account for 57.9% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SPRING BIO SOLUTION | $11.6K | 4 | 18.5% |
| 2 | M/S RAFF & HALL PHARMACY | $7.4K | 7 | 11.8% |
| 3 | Pharmaceutical Buyers Inc | $7.3K | 3 | 11.6% |
| 4 | PHARMACEUTICAL BUYERS, INC | $5.5K | 2 | 8.7% |
| 5 | Espee Biopharma Finechem LLC | $4.6K | 3 | 7.4% |
| 6 | M/S ESPEE BIOPHARMA & FINECHEM LLC | $4.4K | 4 | 7.0% |
| 7 | GOOD HEALTH PARMA SUPPLIES | $3.4K | 6 | 5.3% |
| 8 | RAFF & HALL PHARMACY | $3.2K | 3 | 5.0% |
| 9 | SUTPHIN DRUGS INC | $2.8K | 1 | 4.5% |
| 10 | AMSTERDAM PHARMA (APTEKA RX INC.) | $2.6K | 7 | 4.2% |
| 11 | AMSTERDAM PHARMA (APTEKA RX. INC) | $1.8K | 2 | 2.9% |
| 12 | AMSTERDAM PHARMA (APTEKA RX INC) | $1.5K | 5 | 2.4% |
| 13 | AMSTERDAM PHARMA APTEKA RX INC | $1.3K | 2 | 2.1% |
| 14 | ACTAVIS LABORATORIES UT INC | $1.1K | 2 | 1.8% |
| 15 | M/S REGIONAL PHARMACY | $935 | 3 | 1.5% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | LAURUS LABS LTD | $9.9K | 3 | 15.8% |
| 2 | LAURUS LABS LIMITED | $7.4K | 18 | 11.7% |
| 3 | WATSON PHARMA PVT LTD | $7.3K | 3 | 11.6% |
| 4 | GRAVITI PHARMACEUTICALS PRIVATE LIMITED | $6.5K | 10 | 10.4% |
| 5 | WATSON PHARMA PRIVATE LIMITED | $6.1K | 3 | 9.8% |
| 6 | MSN LABORATORIES PRIVATE LIMITED | $4.5K | 6 | 7.2% |
| 7 | ZYDUS LIFESCIENCES LIMITED | $3.7K | 10 | 6.0% |
| 8 | AJANTA PHARMA LIMITED | $3.5K | 4 | 5.6% |
| 9 | HETERO LABS LIMITED | $3.4K | 8 | 5.3% |
| 10 | OPES HEALTH CARE PRIVATE LIMITED | $2.8K | 1 | 4.5% |
| 11 | JEEVAN SCIENTIFIC TECHNOLOGY LIMITED | $1.8K | 1 | 2.9% |
| 12 | ARISTO PHARMACEUTICALS PRIVATE LIMITED | $1.7K | 1 | 2.7% |
| 13 | ALKEM LABORATORIES LIMITED | $1.3K | 2 | 2.1% |
| 14 | LOTUS LABS PRIVATE LIMITED | $1.1K | 2 | 1.8% |
| 15 | ASPHAR RESEARCH LABS PRIVATE LIMITED | $653 | 10 | 1.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Losartan suppliers from UNITED STATES to India include SPRING BIO SOLUTION, M/S RAFF & HALL PHARMACY, Pharmaceutical Buyers Inc. The leading supplier is SPRING BIO SOLUTION with import value of $11.6K USD across 4 shipments. India imported Losartan worth $62.9K USD from UNITED STATES in total across 98 shipments.
India imported Losartan worth $62.9K USD from UNITED STATES across 98 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Losartan sourced from UNITED STATES include LAURUS LABS LTD, LAURUS LABS LIMITED, WATSON PHARMA PVT LTD. The largest buyer is LAURUS LABS LTD with $9.9K in imports across 3 shipments.
The total value of Losartan imports from UNITED STATES to India is $62.9K USD, across 98 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
98 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists